InvestorsHub Logo
Followers 827
Posts 119481
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 729

Wednesday, 10/20/2021 10:03:22 AM

Wednesday, October 20, 2021 10:03:22 AM

Post# of 803
ABT 3Q21 Results by Business Segment


%Corp YoY Growth
Segment Sales (const currency)

Medical devices* 33% +13%
Diagnostics 36% +47%
Nutrition 19% +9%
Drugs† 12% +15%


3Q21 COVID-19 diagnostics sales were $1.9B, 49% of total 3Q21 diagnostics sales.

60% of overall corporate sales were ex-US.

*Includes diabetes care.
†Branded generics in emerging markets.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABT News